374 studies found for:    Open Studies | "Sarcoma"
Show Display Options
Rank Status Study
21 Not yet recruiting Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
Conditions: AIDS-related Kaposi Sarcoma;   HIV Infection;   Recurrent Kaposi Sarcoma
Interventions: Drug: gamma secretase inhibitor PF-03084014;   Other: pharmacological study;   Other: laboratory biomarker analysis
22 Recruiting Assessment of Blood Vessel Density in Kaposi s Sarcoma Lesions
Condition: Kaposi's Sarcoma
Intervention:
23 Recruiting Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Condition: Sarcoma, Alveolar Soft Part
Intervention: Drug: AZD2171
24 Recruiting Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Condition: Sarcoma, Kaposi
Interventions: Drug: Liposomal Doxorubicin;   Drug: Bevacizumab
25 Recruiting A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Conditions: Kaposi's Sarcoma;   HIV+;   HIV Positive;   AIDS
Intervention: Drug: aldoxorubicin
26 Recruiting Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma
Conditions: Stage IIB Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: Epirubicin Hydrochloride;   Radiation: External Beam Radiation Therapy;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Drug: Sorafenib Tosylate;   Procedure: Therapeutic Conventional Surgery
27 Recruiting Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
Conditions: Gastrointestinal Stromal Tumor;   Recurrent Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: Dasatinib;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
28 Recruiting Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
Conditions: Stage IIA Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: Pazopanib Hydrochloride;   Drug: Doxorubicin Hydrochloride;   Drug: Ifosfamide;   Other: Placebo;   Procedure: Therapeutic Conventional Surgery;   Radiation: External Beam Radiation Therapy;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
29 Recruiting Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
Conditions: Neuroblastoma;   Sarcoma
Intervention: Drug: Cyclophosphamide, Topotecan, and Bevacizumab
30 Recruiting Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Conditions: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Osteosarcoma
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis
31 Recruiting Study in Localized and Disseminated Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Zoledronic acid;   Drug: Busulfan;   Drug: Treosulfan
32 Unknown  Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
33 Recruiting Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
Condition: Sarcoma
Interventions: Genetic: Autologous HER2-specific T cells;   Drug: Fludarabine;   Drug: Cyclophosphamide
34 Recruiting Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
Conditions: Osteosarcoma;   Paget's Disease;   Ewing Sarcoma
Intervention: Other: DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI
35 Unknown  Sarcoma Database at KFSH&RC
Condition: Sarcoma Database
Intervention: Other: Database
36 Recruiting A Pilot Study of Genetically Engineered NY-ESO-1 Specific (c259) T Cells in HLA-A2+ Patients With Synovial Sarcoma
Condition: Synovial Sarcoma
Intervention: Biological: NY-ESO-1 T Cells
37 Recruiting Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Standard treatment (as per protocol ISG SSG III);   Drug: Intensified chemotherapy
38 Unknown  Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Intervention: Drug: Bevacizumab
39 Recruiting A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas
Conditions: Soft Tissue Sarcoma;   Bone Sarcoma
Intervention: Drug: Pembrolizumab
40 Unknown  Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX
Condition: Sarcoma
Interventions: Genetic: microarray analysis;   Genetic: molecular diagnostic method;   Other: biologic sample preservation procedure

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years